Risk of infection associated with daratumumab treatment for Multiple Myeloma

被引：0
|
作者：
Yousif, Ammar [1 ]
Cui, Haiyan [1 ]
Russell, Samantha [2 ]
Larsen, Ashley [2 ]
Gowin, Krisstina [1 ]
机构：
[1] Univ Arizona, Ctr Canc, Tucson, AZ USA
[2] Univ Arizona, Coll Med, Tucson, AZ USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2020年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-39
引用
收藏
页码：S32 / S33
页数：2
相关论文
共 50 条
  • [1] Hypogammaglobulinemia and Risk of Infection Following Daratumumab in Patients with Multiple Myeloma
    Hong, Joseph
    Zhou, Baijun
    Pak, Andrew
    Yang, Nancy
    Barmettler, Sara
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB231 - AB231
  • [2] Daratumumab for the Treatment of Multiple Myeloma
    Plesner, Torben
    Krejcik, Jakub
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [3] Daratumumab for the treatment of multiple myeloma
    Touzeau, Cyrille
    Moreau, Philippe
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (07) : 887 - 893
  • [4] Daratumumab for the treatment of multiple myeloma
    Goldsmith, S. R.
    Foley, N.
    Schroeder, M. A.
    [J]. DRUGS OF TODAY, 2021, 57 (10) : 591 - 605
  • [5] TREATMENT WITH DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA ASSOCIATED AL AMYLOIDOSIS
    Fazio, F.
    Basset, M.
    Milani, P.
    Foli, A.
    Nuvolone, M.
    Foa, R.
    Petrucci, M. T.
    Merlini, G.
    Palladini, G.
    [J]. HAEMATOLOGICA, 2019, 104 : 11 - 11
  • [6] Treatment with Daratumumab in Patients with Multiple Myeloma Associated AL Amyloidosis
    Milani, Paolo
    Fazio, Francesca
    Basset, Marco
    Berno, Tamara
    Larocca, Alessandra
    Foli, Andrea
    Riva, Marcello
    Oliva, Stefania
    Ripepi, Jessica
    Nuvolone, Mario
    Petrucci, Maria Teresa
    Merlini, Giampaolo
    Palladini, Giovanni
    [J]. BLOOD, 2019, 134
  • [7] The safety of daratumumab for the treatment of multiple myeloma
    Cejalvo, Maria J.
    Ribas, Paz
    de la Rubia, Javier
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (06) : 753 - 760
  • [8] Daratumumab subcutaneous formulation for the treatment of multiple myeloma
    Paul, Barry
    Hamadeh, Issam
    Atrash, Shebli
    Bhutani, Manisha
    Voorhees, Peter
    Usmani, Saad Z.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (11) : 1253 - 1259
  • [9] Potential role of daratumumab in the treatment of multiple myeloma
    Khagi, Yulian
    Mark, Tomer M.
    [J]. ONCOTARGETS AND THERAPY, 2014, 7 : 1095 - 1100
  • [10] An evaluation of subcutaneous daratumumab for the treatment of multiple myeloma
    Paul, Barry
    Atrash, Shebli
    Bhutani, Manisha
    Voorhees, Peter
    Hamadeh, Issam
    Usmani, Saad Z.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (08) : 795 - 802
12345